tirzepatide/niacinamide brand name Tirzepatide is the dual-action one. Instead of working on a single hormone, it targets two — GLP-1 and GIP — which is why it tends to have a stronger effect on appetite Tirzepatide / Niacinamide Injection |

GLP-1 receptor agonists are known to lower inflammation throughout the body, enhance insulin sensitivity, and promote weight loss -- all factors that can influence cancer growth and progression

This is especially beneficial for individuals with conditions like prediabetes or type 2 diabetes, where managing blood sugar is crucial for overall health

Finerenone is effective at reducing cardiorenal events, but it doesnt treat diabetes

Note: This is a significant update because a diagnosis of Parkinsons disease will now be directed by the Alphabetic index to code G20.A1 rather than G20.C

Antiobesity therapeutics with complementary dual-agonist activities at glucagon and glucagon-like peptide 1 receptors

For a detailed guide on protecting muscle during GLP-1 therapy, see: Prevent Muscle Loss on GLP-1